Show simple item record

Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-alpha Treatment

dc.contributor.authorDuman, Berna
dc.contributor.authorMusellim, Benan
dc.contributor.authorMazican, Nejdiye
dc.contributor.authorHamuryudan, Vedat
dc.contributor.authorOzguler, Yesim
dc.contributor.authorOngen, Gul
dc.contributor.authorAtahan, Ersan
dc.contributor.authorYilmaz, Deniz Demir
dc.contributor.authorBorekci, Sermin
dc.date.accessioned2021-03-03T14:07:57Z
dc.date.available2021-03-03T14:07:57Z
dc.date.issued2015
dc.identifier.citationBorekci S., Atahan E., Yilmaz D. D. , Mazican N., Duman B., Ozguler Y., Musellim B., Hamuryudan V., Ongen G., "Factors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-alpha Treatment", RESPIRATION, cilt.90, sa.3, ss.191-198, 2015
dc.identifier.issn0025-7931
dc.identifier.otherav_37ea9a98-2806-4826-ac0d-168d0c162dd0
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/41697
dc.identifier.urihttps://doi.org/10.1159/000434684
dc.description.abstractBackground: Tumor necrosis factor (TNF)-alpha inhibitors are known to increase the risk of tuberculosis (TB). Objectives: To examine the factors associated with an increased risk of TB in patients receiving anti-TNF-alpha treatment (aTNF-alpha-T).
dc.language.isoeng
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectSOLUNUM SİSTEMİ
dc.titleFactors Affecting the Tuberculosis Risk in Patients Receiving Anti-Tumor Necrosis Factor-alpha Treatment
dc.typeMakale
dc.relation.journalRESPIRATION
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume90
dc.identifier.issue3
dc.identifier.startpage191
dc.identifier.endpage198
dc.contributor.firstauthorID57458


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record